Trial Search Results
Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors
This clinical trial studies how well yttrium Y 90 glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors. Images produced by PET/CT may provide better information about the distribution of particles, such as yttrium Y 90 glass microspheres, delivered for selective internal radiation therapy (SIRT) compared to the technetium Tc-99m albumin aggregated single photon emission computed tomography (SPECT)/CT images.
Stanford is currently accepting patients for this trial.
- Diagnostic Test: Computed Tomography
- Diagnostic Test: Positron Emission Tomography
- Device: Yttrium Y 90 Glass Microspheres
- Patient provides written informed consent
- Patient is referred for 90Y SIRT radioembolization of liver tumor(s)
- Patient is capable of complying with study procedures
- Patient is able to remain still for duration of imaging procedure (approximately 30
minutes total for digital PET/CT)
- Patient is pregnant or nursing
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study